The impact of high eosinophil count on hospitalizations in COPD patients

B. Arpinar Yigitbas (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), E. Yazar (Istanbul, Turkey), L. Kilic (Istanbul, Turkey), C. Satici (Istanbul, Turkey), S. Ozden (Istanbul, Turkey)

Source: International Congress 2018 – Biomarkers of COPD
Session: Biomarkers of COPD
Session type: Thematic Poster
Number: 4068
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Arpinar Yigitbas (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), E. Yazar (Istanbul, Turkey), L. Kilic (Istanbul, Turkey), C. Satici (Istanbul, Turkey), S. Ozden (Istanbul, Turkey). The impact of high eosinophil count on hospitalizations in COPD patients. 4068

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD
Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018
Year: 2018



Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017

The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Blood eosinophil count predicts treatment failure and hospital readmission for COPD
Source: ERJ Open Res, 6 (4) 00188-2020; 10.1183/23120541.00188-2020
Year: 2020



Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Mepolizumab in patients =3 exacerbations and eosinophil count =300 cells/µL
Source: International Congress 2017 – Asthma management
Year: 2017

Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


The impact of eosinophil levels on current prescribing in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Definition of COPD phenotype depending on eosinophil count
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation?
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Variability in eosinophil levels at start of severe exacerbations of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020